The investment thesis highlights Solstice Advanced Materials (SOLS), a recent Honeywell (HON) spin-off, as a significantly undervalued asset with a price target of $150/share. The bullish sentiment is driven by its AES segment, which operates the only domestic US uranium conversion plant, benefiting from a $2B backlog and the expiration of legacy $20/kgU contracts as spot prices reach $64/kgU. Analysts compare SOLS's current 7.5x '28 EV/EBITDA valuation to peers like Centrus Energy (LEU) at 33x and Cameco (CCJ) at over 40x.